Projected Income Statement: Exelon Corporation

Forecast Balance Sheet: Exelon Corporation

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
Net Debt 1 38,670 41,235 39,077 43,563 46,292 49,750 53,824 56,594
Change - 6.63% -5.23% 11.48% 6.26% 7.47% 8.19% 5.15%
Announcement Date 24/02/21 25/02/22 14/02/23 21/02/24 12/02/25 12/02/26 - -
1USD in Million
Estimates

Cash Flow Forecast: Exelon Corporation

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
CAPEX 1 8,048 7,981 7,147 7,408 7,097 8,854 9,969 9,681
Change - -0.83% -10.45% 3.65% -4.2% 24.76% 12.59% -2.89%
Free Cash Flow (FCF) 1 -3,813 -4,969 -2,277 -2,705 -1,528 -48 -816 -210
Change - -30.32% 54.18% -18.8% 43.51% 96.86% -1,600% 74.26%
Announcement Date 24/02/21 25/02/22 14/02/23 21/02/24 12/02/25 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Exelon Corporation

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027

Profitability

        
EBITDA Margin (%) 25.65% 23.55% 34.81% 34.65% 34.36% 36.21% 39.3% 39.37%
EBIT Margin (%) 13.32% 6.94% 17.39% 18.52% 18.76% 21.21% 22.29% 22.66%
EBT Margin (%) 7.06% 6.07% 12.6% 12.44% 11.58% 13.57% 14.36% 14.41%
Net margin (%) 5.94% 4.69% 11.37% 10.71% 10.68% 11.41% 11.39% 11.98%
FCF margin (%) -11.54% -13.67% -11.94% -12.45% -6.64% -0.2% -3.24% -0.81%
FCF / Net Income (%) -194.24% -291.27% -104.93% -116.19% -62.11% -1.79% -28.39% -6.77%

Profitability

        
ROA 2.48% 2.11% 1.9% 2.36% 2.35% 2.49% 2.55% 2.63%
ROE 9.72% 8.25% 7.34% 9.41% 9.34% 9.82% 9.8% 9.95%

Financial Health

        
Leverage (Debt/EBITDA) 4.56x 4.82x 5.88x 5.79x 5.85x 5.67x 5.43x 5.55x
Debt / Free cash flow -10.14x -8.3x -17.16x -16.1x -30.3x -1,036.46x -65.96x -269.49x

Capital Intensity

        
CAPEX / Current Assets (%) 24.36% 21.96% 37.46% 34.1% 30.82% 36.51% 39.52% 37.39%
CAPEX / EBITDA (%) 94.95% 93.26% 107.6% 98.39% 89.69% 100.98% 100.56% 94.97%
CAPEX / FCF (%) -211.07% -160.62% -313.88% -273.86% -464.46% -18,446.25% -1,221.69% -4,609.96%

Items per share

        
Cash flow per share 1 4.335 3.073 - 4.717 5.552 6.256 6.577 -
Change - -29.1% - - 17.7% 12.67% 5.13% -
Dividend per Share 1 1.53 1.53 1.35 1.44 1.52 1.596 1.688 1.771
Change - 0% -11.76% 6.67% 5.56% 4.97% 5.82% 4.88%
Book Value Per Share 1 33.39 35.13 - 25.78 26.84 28.24 29.49 30.89
Change - 5.23% - - 4.11% 5.2% 4.44% 4.73%
EPS 1 2.01 1.74 2.19 2.34 2.45 2.73 2.832 3.019
Change - -13.43% 25.86% 6.85% 4.7% 11.43% 6.08% 6.58%
Nbr of stocks (in thousands) 9,75,572 9,78,318 9,93,742 9,95,437 10,04,834 10,10,290 10,10,290 10,10,290
Announcement Date 24/02/21 25/02/22 14/02/23 21/02/24 12/02/25 12/02/26 - -
1USD
Estimates
2025 2026 *
P/E ratio 16x 16.8x
PBR 1.68x 1.61x
EV / Sales 1.82x 4.04x
Yield 3.36% 3.55%

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
47.55USD
Average target price
48.75USD
Spread / Average Target
+2.52%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. EXC Stock
  4. Financials Exelon Corporation